Harbour Investments, Inc. Recursion Pharmaceuticals, Inc. Transaction History

Harbour Investments, Inc.

  • $3.59 Billion
  • Q2 2025

A detailed history of Harbour Investments, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 1,296 shares of RXRX stock, worth $7,153. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,296
Previous 1,396 7.16%
Holding current value
$7,153
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025
SELL
$3.97 - $5.84 $397 - $584
-100 Reduced 7.16%
1,296 $6,000
Q1 2025

May 08, 2025
BUY
$5.29 - $10.87 $2,094 - $4,304
396 Added 39.6%
1,396 $7,000
Q3 2024

Nov 04, 2024
BUY
$5.92 - $8.6 $5,920 - $8,600
1,000 New
1,000 $6,000

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $996M
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email